Dimitrios Bafaloukos Selected Research

Dimitrios Bafaloukos Research Topics

Disease

40	Neoplasms (Cancer) 03/2023 - 03/2003
36	Breast Neoplasms (Breast Cancer) 12/2023 - 07/2005
20	Melanoma (Melanoma, Malignant) 12/2023 - 12/2002
11	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 03/2003
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 02/2007
9	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2004
8	Carcinoma (Carcinomatosis) 05/2017 - 06/2002
6	Disease Progression 01/2018 - 07/2005
4	Colonic Neoplasms (Colon Cancer) 12/2019 - 01/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2014
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 01/2013
2	Anemia 02/2016 - 06/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2010 - 10/2008
2	Endometrial Neoplasms (Endometrial Cancer) 10/2008 - 07/2008
2	Febrile Neutropenia 07/2005 - 06/2004
1	Rupture 12/2023
1	COVID-19 03/2023
1	Gastritis 11/2022
1	Periodontal Diseases (Periodontal Disease) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Colitis 11/2019

Drug/Important Bio-Agent (IBA)

17	ParaffinIBA 12/2019 - 11/2006
17	Paclitaxel (Taxol)FDA LinkGeneric 07/2015 - 06/2002
15	Messenger RNA (mRNA)IBA 03/2023 - 11/2006
14	Formaldehyde (Formol)FDA Link 12/2019 - 07/2009
13	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2009
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2008
10	Trastuzumab (Herceptin)FDA Link 10/2022 - 10/2012
10	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2005
10	AnthracyclinesIBA 01/2022 - 07/2008
10	Fluorouracil (Carac)FDA LinkGeneric 12/2019 - 03/2003
8	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 07/2008
8	Carboplatin (JM8)FDA LinkGeneric 06/2010 - 09/2004
7	Taxoids (Taxanes)IBA 01/2022 - 10/2004
7	Cisplatin (Platino)FDA LinkGeneric 02/2015 - 06/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2006
6	Leucovorin (Folinic Acid)FDA Link 12/2019 - 03/2003
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 04/2012
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 07/2005
5	Hormones (Hormone)IBA 01/2020 - 06/2006
5	Bevacizumab (Avastin)FDA Link 01/2020 - 09/2011
5	Irinotecan (Camptosar)FDA LinkGeneric 12/2019 - 03/2003
5	Monoclonal AntibodiesIBA 11/2018 - 10/2008
5	RNA (Ribonucleic Acid)IBA 07/2015 - 11/2006
4	Docetaxel (Taxotere)FDA Link 12/2023 - 01/2006
4	Immune Checkpoint InhibitorsIBA 06/2023 - 02/2015
4	NivolumabIBA 06/2023 - 01/2019
4	human ERBB2 proteinIBA 10/2022 - 06/2012
4	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2005
4	LigandsIBA 01/2022 - 06/2012
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2019 - 07/2005
4	Vascular Endothelial Growth Factor CIBA 01/2018 - 11/2012
4	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 02/2006
4	InterferonsIBA 01/2016 - 12/2002
4	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 04/2012
4	Estrogen ReceptorsIBA 11/2012 - 07/2009
4	Progesterone Receptors (Progesterone Receptor)IBA 11/2012 - 07/2009
4	Gemcitabine FDA Link 10/2008 - 09/2004
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2019
3	Cetuximab (Erbitux)FDA Link 05/2014 - 05/2011
3	PlatinumIBA 01/2010 - 09/2004
3	liposomal doxorubicin (Doxil)FDA Link 01/2010 - 06/2004
3	Interferon alpha-2 (Roferon-A)FDA Link 02/2009 - 05/2004
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2008 - 07/2005
3	Gefitinib (Iressa)FDA Link 10/2008 - 07/2005
2	dabrafenibIBA 12/2023 - 05/2021
2	trametinibIBA 12/2023 - 05/2021
2	VaccinesIBA 03/2023 - 03/2022
2	Protein Isoforms (Isoforms)IBA 04/2021 - 12/2019
2	IpilimumabIBA 11/2019 - 01/2019
2	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2018 - 01/2014
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2015 - 07/2015
2	Temozolomide (Temodar)FDA LinkGeneric 02/2015 - 01/2005
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2015 - 05/2014
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2012 - 07/2009
2	taxaneIBA 09/2011 - 07/2005
2	Platinum Compounds (Compounds, Platinum)IBA 10/2008 - 07/2008
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2008 - 08/2008
2	Topotecan (Hycamtin)FDA LinkGeneric 10/2008 - 01/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2008 - 06/2004
2	1-dodecylpyridoxal (PLD)IBA 07/2005 - 06/2004
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2023
1	mRNA VaccinesIBA 03/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2023
1	trastuzumab deruxtecanIBA 02/2023
1	Immunoconjugates (Immunoconjugate)IBA 02/2023
1	antineoplaston A10 (A 10)IBA 11/2022
1	COVID-19 VaccinesIBA 03/2022
1	Therapeutic UsesIBA 03/2022
1	AfatinibIBA 01/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	Cyclin-Dependent Kinase 4IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 12/2023 - 03/2003
18	Therapeutics 12/2023 - 03/2003
14	Adjuvant Chemotherapy 11/2022 - 03/2003
3	Immunotherapy 03/2023 - 02/2006
2	Precision Medicine 01/2020 - 05/2011